BR0010558A - Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico - Google Patents

Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico

Info

Publication number
BR0010558A
BR0010558A BR0010558-9A BR0010558A BR0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A BR 0010558 A BR0010558 A BR 0010558A
Authority
BR
Brazil
Prior art keywords
methods
gastric cancer
predict
cancer risk
risk
Prior art date
Application number
BR0010558-9A
Other languages
English (en)
Inventor
Robert Llewellyn Clancy
Gerald Pang
Original Assignee
Onco Alert Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Alert Pty Ltd filed Critical Onco Alert Pty Ltd
Publication of BR0010558A publication Critical patent/BR0010558A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "MéTODOS PARA PROGNOSTICAR E/OU DIAGNOSTICAR O RISCO DE CâNCER GáSTRICO". A presente invenção refere-se a métodos de prognosticar o risco de desenvolver câncer e em particular a um método para diagnosticar e/ou prognosticar o risco de desenvolver câncer gástrico em um indivíduo infectado com Heliobacter.
BR0010558-9A 1999-05-14 2000-05-15 Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico BR0010558A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
BR0010558A true BR0010558A (pt) 2002-02-19

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010558-9A BR0010558A (pt) 1999-05-14 2000-05-15 Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico

Country Status (10)

Country Link
EP (1) EP1183540A4 (pt)
JP (1) JP2002544520A (pt)
KR (1) KR20020033093A (pt)
CN (1) CN1355885A (pt)
AU (1) AUPQ037799A0 (pt)
BR (1) BR0010558A (pt)
CA (1) CA2372761A1 (pt)
HK (1) HK1044988A1 (pt)
MX (1) MXPA01011721A (pt)
WO (1) WO2000070348A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
JP2014530350A (ja) * 2011-09-14 2014-11-17 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 腎臓毒性を評価するための手段及び方法
JP6707248B2 (ja) * 2013-12-05 2020-06-10 学校法人北里研究所 胃癌細胞の検出方法、及び胃癌細胞検出キット
RU2706118C1 (ru) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Способ прогнозирования предраковых заболеваний желудка
CN115537465A (zh) * 2022-02-28 2022-12-30 陈芳芳 Sctag在胃癌癌前预警和靶向药物中的应用
CN117143234B (zh) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 抗大鼠白细胞介素-4蛋白的单克隆抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (it) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua

Also Published As

Publication number Publication date
EP1183540A1 (en) 2002-03-06
WO2000070348A1 (en) 2000-11-23
JP2002544520A (ja) 2002-12-24
KR20020033093A (ko) 2002-05-04
AUPQ037799A0 (en) 1999-06-10
MXPA01011721A (es) 2003-09-10
HK1044988A1 (zh) 2002-11-08
EP1183540A4 (en) 2007-07-04
CN1355885A (zh) 2002-06-26
CA2372761A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
EP1572091A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
EP1578371A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
DK0749325T3 (da) Bispecifikke molekyler med klinisk anvendelse
EP1575571A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF A TUMOR
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
AU2003230838A8 (en) Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
WO2008070137A3 (en) Interferon alpha-induced pharmacodynamic markers
BR9907256A (pt) Inibidores beta-cetoamida de proteassoma 20s
BRPI0503443A (pt) verificação de caso teste automatizada que é acoplada de forma livre em relação à execução de caso teste automatizado
ATE424560T1 (de) Marker für neuromyelitis optica
EP1466179A4 (en) METHOD FOR DIAGNOSING CANCERS BY MEASURING CHANGES IN GLYCOSILATION OF TUMORIGENESIS-RELATED PROTEINS AND METASTASES AND CANCER DIAGNOSTIC KIT USING THE SAME
BR0011303A (pt) Sistema para realizar gerenciamento de carga
WO1999016888A3 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
BR0115715A (pt) Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
DK1075277T4 (da) Fremgangsmåder til detektion og inhibering af angiogenese
ATE404118T1 (de) System für kontinuierliche leistungstests
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
BR9307593A (pt) Dispositivo para realização de testes de urease combinados em biópsias de antro/corpo para diagnóstico de doenças gastrointestinais
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DK1565490T3 (da) Holo-transcobalamin bindingspartnere og deres anvendelse i cobalamintest
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADDE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.